DeepMed Research

The Vanderbilt University

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2009-05-12

Last Posted Date: 2013-04-02

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 74

Registration Number: NCT00898664

Collecting and Storing Tissue Samples From Women With or Without Breast Cancer

Recruiting

Conditions: Breast Cancer

Interventions: Other: biologic sample preservation procedure

First Posted Date: 2009-05-12

Last Posted Date: 2024-08-26

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 4000

Registration Number: NCT00899301

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

Recruiting

Conditions: Lung Cancer

Interventions: Genetic: comparative genomic hybridization
Genetic: gene expression microarray analysis
Genetic: proteomic profiling analysis
Other: biologic sample preservation procedure
Procedure: nasal brushing
Procedure: Blood draw
Procedure: Urine collection
Procedure: sputum sample
Procedure: fluorescence bronchoscopy with airway biopsy
Procedure: fine needle aspiration of the lung
Procedure: thoracentesis

First Posted Date: 2009-05-12

Last Posted Date: 2023-11-22

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 4000

Registration Number: NCT00898313

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
🇺🇸
Veterans Affairs Medical Center - Nashville, Nashville, Tennessee, United States

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Terminated

Conditions: Head and Neck Cancer

Interventions: Genetic: DNA and tissue microarray analysis
Genetic: reverse transcriptase-polymerase chain reaction
Other: mass spectrometry

First Posted Date: 2009-05-12

Last Posted Date: 2013-04-02

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 58

Registration Number: NCT00898742

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

Completed

Conditions: Lung Cancer

Interventions: Genetic: DNA/RNA sequencing and expression levels
Genetic: Protein expression analysis
Procedure: Lung tumor biopsy
Procedure: Blood sample

First Posted Date: 2009-05-12

Last Posted Date: 2017-07-19

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 204

Registration Number: NCT00897650

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer

Recruiting

Conditions: Lung Cancer

Interventions: Genetic: gene expression analysis
Genetic: microarray analysis
Genetic: protein expression analysis
Other: biologic sample preservation procedure
Other: laboratory biomarker analysis
Other: matrix-assisted laser desorption/ionization time of flight mass spectrometry

First Posted Date: 2009-05-12

Last Posted Date: 2024-05-22

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 4000

Registration Number: NCT00897117

Locations: 🇺🇸
Dan Rudy Cancer Center at Saint Thomas Hospital, Nashville, Tennessee, United States
🇺🇸
Veterans Affairs Medical Center - Nashville, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

Terminated

Conditions: Melanoma

First Posted Date: 2009-05-12

Last Posted Date: 2016-04-25

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 7

Registration Number: NCT00897312

Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer

Phase 1

Terminated

Conditions: Lung Cancer
Metastatic Cancer

Interventions: Drug: RAD001
Radiation: whole-brain radiation therapy

First Posted Date: 2009-05-05

Last Posted Date: 2012-03-12

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 5

Registration Number: NCT00892801

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery

Phase 2

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: Sorafenib
Drug: Erlotinb

First Posted Date: 2009-02-06

Last Posted Date: 2014-06-25

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 37

Registration Number: NCT00837876

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States
🇺🇸
Purchase Cancer Group - Paducah, Paducah, Kentucky, United States

and more 3 locations

Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma

Phase 2

Completed

Conditions: Lymphoma

Interventions: Drug: Lenalidomide
Drug: Rituximab

First Posted Date: 2008-10-02

Last Posted Date: 2016-04-11

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 44

Registration Number: NCT00765245

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy